DATATRAK to Exhibit at the 2012 ASCO Annual Meeting
CLEVELAND, May 30, 2012 /PRNewswire/ -- DATATRAK International, Inc. (OTCQX: DATA), a technology and services company focused on global eClinical solutions for the clinical trials industry, today announced its attendance at the 2012 American Society of Clinical Oncology (ASCO) Annual Meeting to be held June 1st – 5th at the McCormick Place in Chicago, IL.
DATATRAK will be demonstrating the DATATRAK ONE™ unified software suite in Booth #18125 in the Oncology Professionals Hall on June 2nd – 4th. Visit the booth to learn how DATATRAK ONE™ and its oncology-specific solution can safely accelerate your drug development timelines from Concept to Cure®.
DATATRAK ONE™ is a comprehensive cloud-based global clinical research platform helping customers with the strategy, planning and management of their entire life science product portfolio, including resource management, study execution needs and safety reporting.
About ASCO Annual Meeting
The Annual Meeting is the premier educational and scientific event in the oncology community, and this year's theme is 'Collaborating to Conquer Cancer'. With more than 30,000 members, ASCO is committed to improving cancer care through scientific meetings, educational programs and peer-reviewed journals. For ASCO information and resources, visit http://www.asco.org.
DATATRAK International is a worldwide technology and services company delivering eClinical solutions and related services for the clinical trials industry. DATATRAK built its multi-component, comprehensive solution on a single, unified platform and expanded this concept to include services delivery via DATATRAK's Clinical and Consulting Services™ group. The Company delivers a complete portfolio of software products designed to accelerate the reporting of clinical research data from sites to sponsors and ultimately regulatory authorities, faster and more efficiently than loosely integrated technologies. The DATATRAK ONE™ software solution, deployed worldwide through an ASP or Enterprise Transfer offering, supports Phase I - Phase IV drug and devices studies in multiple languages throughout the world. DATATRAK has offices located in Cleveland, Ohio; Bryan, Texas; and Cary (RTP), North Carolina. For more information, visit http://www.datatrak.net.
Except for the historical information contained in this press release, the statements made in this release are forward-looking statements. These forward-looking statements are made based on management's expectations, assumptions, estimates and current beliefs concerning the operations, future results and prospects of the Company and are subject to uncertainties and factors which are difficult to predict and, in many instances, are beyond the control of the Company, and which could cause actual results to differ materially from those contemplated in these forward-looking statements. For a list of certain of the factors that may cause actual results to differ materially from those contemplated in these forward looking statements, please see the Company's quarterly report filed with the OTCQX Market on May 10, 2012 announcing its results for the three-month period ending March 31, 2012. The Company undertakes no obligation to update publicly or revise any forward-looking statement whether as a result of new information, future events or otherwise.
SOURCE DATATRAK International, Inc.
More by this Source
DATATRAK Reports Record Setting Results in 2013
Mar 12, 2014, 17:34 ET
DATATRAK Thought Leadership Featured in March Global Industry Events
Mar 04, 2014, 07:30 ET
DATATRAK ONE® Enters Preclinical Trials Extending Leadership Across All Trial Phases
Feb 04, 2014, 07:30 ET
Browse our custom packages or build your own to meet your unique communications needs.
Learn about PR Newswire services
Request more information about PR Newswire products and services or call us at (888) 776-0942.